论文部分内容阅读
通过检测51例妇科良性肿瘤及32例妇科恶性肿瘤患者血清C—反应性蛋白(CRP),发现妇科恶性肿瘤病人血清CRP含量明显增高。良性肿瘤病人血清CRP均为阴性,CRP含量的变化反映妇科恶性肿瘤的严重程度,CRP含量越高妇科恶性肿瘤患者期别越晚。其中卵巢癌病人C—反应性蛋白的阳性检测率100％,但3例恶性葡萄胎病人CRP为阴性,其原因有待于进一步探讨。本文提示:CRP的检测可用于妇科恶性肿瘤的辅助诊断、良恶性肿瘤的鉴别、恶性肿瘤的预后及恶性肿瘤病人化疗疗效的预测。
By detecting 51 cases of gynecological benign tumors and 32 cases of gynecologic malignancies in patients with serum C-reactive protein (CRP), found that patients with gynecologic malignancies serum CRP levels were significantly increased. Serum CRP in patients with benign tumors were negative, CRP levels reflect changes in the severity of gynecological malignancies, the higher the CRP content gynecological malignant tumor patients later. The positive detection rate of C-reactive protein in ovarian cancer patients was 100%, but the CRP in 3 cases of malignant hydatidiform mole patients was negative, the reason needs to be further explored. This article suggests that the detection of CRP can be used for the auxiliary diagnosis of gynecological malignancies, the identification of benign and malignant tumors, the prognosis of malignant tumors and the prediction of chemotherapy efficacy in patients with malignant tumors.